Invention Grant
US07767850B2 S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline salt
有权
S- [2 - [(1-亚氨基)氨基]乙基] -2-甲基-L-半胱氨酸马来酸盐盐酸盐结晶盐
- Patent Title: S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline salt
- Patent Title (中): S- [2 - [(1-亚氨基)氨基]乙基] -2-甲基-L-半胱氨酸马来酸盐盐酸盐结晶盐
-
Application No.: US12315744Application Date: 2008-12-05
-
Publication No.: US07767850B2Publication Date: 2010-08-03
- Inventor: Lyle Brostrom , Ann Czyzewski , Vahid Zia , Ahmad Sheikh
- Applicant: Lyle Brostrom , Ann Czyzewski , Vahid Zia , Ahmad Sheikh
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. David Joran; Philip B. Polster, II
- Main IPC: C07C323/25
- IPC: C07C323/25
![S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline salt](/abs-image/US/2010/08/03/US07767850B2/abs.jpg.150x150.jpg)
Abstract:
A novel mixed salt of S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine is disclosed. The novel mixed salt, S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, may be produced to form crystals that may be arranged as generally orderly packed agglomerates, which are particularly useful in making pharmaceutical compositions. Such pharmaceutical compositions are also described, as well as methods to make crystalline S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, and methods of treating conditions characterized by an overexpression on nitric oxide from the inducible isoform of nitric oxide synthase using the S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride.
Public/Granted literature
- US20090215891A1 S-[2-[(1-lminoethy)Amino]Ethyl]-2-Methyl-L-Cysteine Maleate Hydrochloride Crystalline Salt Public/Granted day:2009-08-27
Information query